Asthma biomarkers: what constitutes a ‘gold standard’? | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Editorial

Asthma biomarkers: what constitutes a ‘gold standard’?

Free

Authors

Joseph R Arron Genentech Research and Early Development, South San Francisco, California, USA PubMed articles Google scholar articles
Kenji Izuhara Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan PubMed articles Google scholar articles

Correspondence to Dr Joseph R Arron, Genentech, Inc., MS 231C, 1 DNA Way, South San Francisco, CA 94080, USA; arron.joseph{at}gene.com

Citation

Arron JR, Izuhara K

Asthma biomarkers: what constitutes a ‘gold standard’?

Thorax 2015;70:105-107.

Publication history

First published November 28, 2014.

Online issue publication

January 14, 2015

Article Versions

Previous version (28 November 2014).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions